— · —

CBLL (CBLL) Stock

$18.81 +3.07% —: CBLL —

Valuation

MetricValue
Price$18.81
Market Cap$713.70M
P/E Ratio-11.62
P/B Ratio4.15
P/S Ratio7.52
EPS (TTM)$0.00
52-Week High$24.33
52-Week Low$10.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-34.19%
ROA-27.04%
ROCE-37.18%
Gross Margin-65.17%
Operating Margin-65.17%
Net Margin-63.51%
Debt/Equity0.16
Current Ratio9.84

Annual Financials (USD)

Metric2022202320242025
Revenue$26.0M$45.0M$65.0M$89.0M
Operating Profit$-36.0M$-30.0M$-40.0M$-58.0M
Net Profit$-37.0M$-29.0M$-40.0M$-53.0M
EPS$-1.59$-1.26$-3.39$-1.46
Op Margin-139.0%-66.4%-60.7%-65.6%

Balance Sheet (USD)

Metric2022202320242025
Total Assets$86.0M$59.0M$225.0M$196.0M
Total Liabilities$173.0M$171.0M$34.0M$40.0M
Cash$68.0M$34.0M$194.0M$40.0M
Borrowings$18.0M$14.0M$22.0M$22.0M

Latest News

Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy? Insider Monkey · Jun 27, 2026 Ceribell Insider Sold Shares Worth $714,870, According to a Recent SEC Filing MT Newswires · Jun 10, 2026 Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes GlobeNewswire · Jun 8, 2026 Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference GlobeNewswire · May 20, 2026 CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records MarketBeat · May 15, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-32.0M$-29.0M$-35.0M$-41.0M
Investing Cash Flow$-2.0M$-3.0M$-3.0M$-119.0M
Financing Cash Flow$0$1.0M$0$0
Net Cash Flow$16.0M$-34.0M$160.0M$-154.0M
Free Cash Flow$-33.0M$-30.0M$-36.0M$-42.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-6.94%
Quick Ratio9.87
Interest Coverage-29.00
Return 1Y3.37%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AUTLAutolus Therapeutics plc $1.46 -13.61% -1.35 — 0.00%
BFLY $8.28 -1.72% -60.65 $2.20B 0.00%
EHABEnhabit Inc $13.80 +0.07% -153.33 $706.91M 0.00%
KIDS $22.77 -0.26% -10.79 $584.85M 0.00%
LAB $0.87 -3.27% -5.30 $339.79M 0.00%

About CBLL

CBLL is led by CEO Xingjuan Chao, publicly traded since 2024.

CBLL stock trades at $18.81 with a market capitalization of $713.70M. The stock is valued at a price-to-earnings (P/E) ratio of -11.62, price-to-book of 4.15, price-to-sales of 7.52. Over the past 52 weeks the stock has ranged between $10.85 and $24.33, and currently trades 22.7% below its 52-week high.

On profitability, CBLL generates a return on equity (ROE) of -34.19%, return on capital employed of -37.18%, an operating margin of -65.17%, a net profit margin of -63.51%.

Related — Stocks

BNY — $152.52 -2.54% CIEN — $412.39 +2.14% CBRS — $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY — $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides